Pathologica 4-07.pdf - Pacini Editore

110
phocyte-rich classical HL has been expanded by including a
nodular form of the process, as proposed by the European
Lymphoma Task Force 41 .
It is worthy of note that HL subtyping should be performed
only in lymph node biopsies at the onset of the of disease: in
fact, chemo- and/or radio-therapy actually modify the
histopathologal picture by inducing a lymphocyte depleted
pattern.
References
1 Hummel M, Marafioti T, Stein H. Immunoglobulin V genes in Reed-
Sternberg cells. New Engl J Med 1999;334:405-6.
2 Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular
LP-Hodgkin’s disease from a clonal expansion of highly mutated germinal
center B cells. New Engl J Med 1997;337:453-8.
3 Izban KF, Nawrocki JF, Alkan S, et al. Monoclonal IgH gene rearrangement
in microdissected nodules from nodular sclerosis
Hodgkin’s disease. Am J Clin Pathol 1998;110:599-606.
4 Bräuninger A, Hansmann M-L, Strickler JG, et al. Identification of
common germinal-center B-cell precursors in two patients with both
Hodgkin’s disease and non-Hodgkin’s lymphoma. N Engl J Med
1999;340:1239-47.
5 Küppers R, Klein U, Hansmann M-L, et al. Cellular origin of human
B-cell lymphomas. New Engl J Med 1999;341:1520-9.
6 Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization
classification of neoplastic diseases of the haematopoietic and
lymphoid tissues: Report of the Clinical Advisory Committee Meeting,
Airlie House, Virginia, November 1997. Histopathology 2000;36:69-
86.
7 Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed-Sternberg
cells represent an expansion of a single clone originating from a germinal
center B-cell with functional immunoglobulin gene rearrangement
but defective immunoglobulin transcription. Blood
2000;95:1443-50.
8 Seitz V, Hummel M, Marafioti T, Anagnostopoulos I, Assaf C, Stein
H. Detection of clonal T-cell receptor gamma-chain gene-rearrangements
in Reed-Sternberg cells of classic Hodgkin’s disease. Blood
2000;95:3020-4.
9 Tzankov A, Zimpfer A, Pehrs AC, et al. Expression of B-cell markers
in classical Hodgkin lymphoma: a tissue microarray analysis of 330
cases. Mod Pathol 2003;16:1141-7.
10 Tzankov A, Bougau C, Kaiser A, et al. Rare expressionof T-cell
markers in classical Hodgkin lymphoma. Mod Pathol
2005;18:1542-9.
11 Jaffe ES. Introduction: Hodgkin’s lymphoma – pathology, pathogenesis,
and treatment. Semin Hematol 1999;36:217-9.
12 Harris NL. Hodgkin’s disease: classification and differential diagnosis.
Mod Pathol 1999;12:159-75.
13 Falini B, Pileri S, Pizzolo G, et al. CD30 Ki-1 molecule: a new cytokine
receptor of tumor necrosis factor superfamily as a tool for diagnosis
and immunotherapy. Blood 1995;85:1-14.
14 Hsu SM, Waldron J, Xie SS, Hsu PL. Hodgkin’s disease and anaplastic
large cell lymphoma revisited. 1. Unique cytokine and cytokine
receptor profile distinguished from that of non-Hodgkin’s lymphomas.
J Biomed Sci 1995;2:302-13.
15 Kadin ME, Liebowitz DN. Cytokines and cytokine receptors in
Hodgkin’s disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT,
Weiss LM, eds. Hodgkin’s disease. Philadelphia: Lippincott Williams
& Wilkins 1999, p. 139.
16 Poppema S, Potters M, Emens R, et al. Immune reactions in classical
Hodgkin’s lymphoma. Semin Hematol 1999;36:253-9.
17 Ohshima K, Sugihara M, Suzumiya J, et al. Basic fibroblast growth
factor and fibrosis in Hodgkin’s disease. Pathol Res Pract
1999;195:149-55.
18 van den Berg A, Visser L, Poppema S: High expression of the CC
chemokine TARC in Reed-Sternberg cells. A possible explanation for
the characteristic T-cell infiltrate in Hodgkin’s lymphoma. Am J
Pathol 1999;154:1685-91.
LINFOMANIA
19 Skinnider BF, Elia AJ, Gascoyne RD, et al. Interleukin 13 and interleukin
13 receptor are frequently expressed by Hodgkin and Reed-
Sternberg cells of Hodgkin lymphoma. Blood 2001;97:250-5.
20 Ohshima K, Akaiwa M, Umeshita R, et al. Interleukin-13 and interleukin-13
receptor in Hodgkin’s disease: possible autocrine mechanism
and involvement in fibrosis. Histopathology 2001;38:368-75.
21 Reynolds GM, Billingham LJ, Gray LJ, et al. Interleukin 6 expression
by Hodgkin/Reed-Sternberg cells is associated with the presence of
‘B’ symptoms and failure to achieve complete remission in patients
with advanced Hodgkin’s disease. Br J Haematol 2002;118:195-201.
22 Doussis-Anagnostopoulou IA, Talks KL, Turley H, et al. Vascular endothelial
growth factor VEGF is expressed by neoplastic Hodgkin-
Reed-Sternberg cells in Hodgkin’s disease. J Pathol 2002;197:677-83.
23 Glimelius I, Edstrom A, Amini RM, et al. IL-9 expression contributes
to the cellular composition in Hodgkin lymphoma. Eur J Haematol
2006;76:278-283.
24 Aldinucci D, Poletto D, Gloghini A, et al. Expression of functional interleukin-3
receptors on Hodgkin and Reed-Sternberg cells. Am J
Pathol 2002;160:585-96.
25 Verbeke CS, Wenthe U, Grobholz R, Zentgraft H. Fas ligand expression
in Hodgkin lymphoma. Am J Surg Pathol 2001;25:388-94.
26 Aldinucci D, Poletto D, Nanni P, et al. Hodgkin and Reed-Sternberg
cells express functional c-kit receptors and interact with primary fibroblasts
from Hodgkin’s disease-involved lymph nodes through solubile
and membrane-bound stem cell factor. Br J Haematol
2002;118:1055-64.
27 Hanamoto H, Nakayama T, Miyazato H, et al. Expression of CCL28
by Reed-Sternberg cells defines a majoir subtype of classical
Hodgkin’s disease with frequent infirltration of eosinophils and/or
plasma cells. Am J Pathol 2004;164:997-1006.
28 Renne C, Willenbrock K, Kuppers R, Hnnsmann ML, Brauninger A.
Aurocrine- and paracrine-activated receptor tyrosine kinases in classic
Hodgkinlymphoma. Blood 2005;105:4051-9.
29 Buri C, Korner M, Scharli P, et al. CC chemokines and the receptors
CCR3 and CCR5 are differentially expressed in the nonneoplastic
leukocytic infiltrates of Hodgkin disease. Blood 2001;97:1543-8.
30 Ohshima K, Tutiya T, Yamaguchi T, et al. Infiltration of Th1 and Th2
lymphocytes around Hodgkin and Reed-Sternberg H&RS cells in
Hodgkin’s disease: relation with expression of CXC and CC chemokines
on H&RS cells. Int J Cancer 2002;98:567-72.
31 Teofili L, Di Febo AL, Pierconti F, et al. Expression of c-met protooncogene
and its ligand hepatocyte growth factor in Hodgkin’s disease.
Blood 2001;97:1063-9.
32 Hodgkin T. On some morbid appearances of the absorbent glands
and spleen. Medico-Chirurgical Trans 1832;17:68-97.
33 Sternberg C. Uber eine eigenartige unter dem Blide der Pseudoleukamie
velaufende Tubercolose des lymphatishen Apparates. Ztschr
Heilk 1898;19:21-90.
34 Reed D. On the pathological changes in Hodgkin’s disease, with special
reference to its relation to tubercolosis. John Hopkins Hosp Rep
1902;10:133-96.
35 Jackson H, Parker F. Hodgkin’s disease. 1. General considerations. N
Engl J Med 1944;230:1-8.
36 Smetana HF, Cohen BM. Mortality in relation to histologic type in
Hodgkin’s disease. Blood 1956;11:211-24.
37 Lukes R, Butler J, Hicks E. Natural history of Hodgkin’s disease as
related to its pathological picture. Cancer 1966;19:317-44.
38 Lukes RJ, Craver L, Hall T, Rappaport H, Ruben P. Report of the nomenclature
committee. Cancer Res 1966;26:1311.
39 Harris NL, Jaffe ES, Stein H, et al. A Revised European-American
classification of lymphoid neoplasms: a proposal from the International
Lymphoma Study Group. Blood 1994;84:1361-92.
40 Stein H, Delsol G, Pileri S, et al. Hodgkin’s lymphoma. In: Jaffe ES,
Harris NL, Stein H, Vardiman JW, eds. Tumours of haematopoietic
and lymphoid tissues. Lyon: IARCPress 2001, p. 237-53.
41 Anagnostopoulos I, Hansmann M-L, Fransilla K, et al. European Task
Force on Lymphoma project on lymphocyte predominance Hodgkin
disease: histologic and immunohistologic analysis of submitted cases
reveals 2 types of Hodgkin disease with a nodular growth pattern and
abudant lymphocytes. Blood 2000;96:1889-99.